JW Pharmaceutical Corporation (KRX:001060)

South Korea flag South Korea · Delayed Price · Currency is KRW
36,200
0.00 (0.00%)
Last updated: Feb 27, 2026, 3:19 PM KST
56.03%
Market Cap 826.01B
Revenue (ttm) 764.21B
Net Income (ttm) 57.97B
Shares Out 22.89M
EPS (ttm) 2,508.80
PE Ratio 14.43
Forward PE n/a
Dividend 450.00 (1.24%)
Ex-Dividend Date Mar 31, 2026
Volume 99,553
Average Volume 183,340
Open 35,800
Previous Close 36,200
Day's Range 35,200 - 36,400
52-Week Range 19,600 - 39,250
Beta 1.12
RSI 61.87
Earnings Date Mar 13, 2026

About JW Pharmaceutical

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is base... [Read more]

Sector Healthcare
Founded 1945
Employees 1,068
Stock Exchange Korea Stock Exchange
Ticker Symbol 001060
Full Company Profile

Financial Performance

In 2024, JW Pharmaceutical's revenue was 719.38 billion, a decrease of -3.89% compared to the previous year's 748.53 billion. Earnings were 60.78 billion, an increase of 64.24%.

Financial Statements

News

There is no news available yet.